These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 15331734)

  • 1. Genome size and structure determine efficiency of postinternalization steps and gene transfer of capsid-modified adenovirus vectors in a cell-type-specific manner.
    Shayakhmetov DM; Li ZY; Gaggar A; Gharwan H; Ternovoi V; Sandig V; Lieber A
    J Virol; 2004 Sep; 78(18):10009-22. PubMed ID: 15331734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction between the fiber knob domain and the cellular attachment receptor determines the intracellular trafficking route of adenoviruses.
    Shayakhmetov DM; Li ZY; Ternovoi V; Gaggar A; Gharwan H; Lieber A
    J Virol; 2003 Mar; 77(6):3712-23. PubMed ID: 12610146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of penton RGD motifs affects the efficiency of both the internalization and the endosome escape of viral particles containing adenovirus serotype 5 or 35 fiber knobs.
    Shayakhmetov DM; Eberly AM; Li ZY; Lieber A
    J Virol; 2005 Jan; 79(2):1053-61. PubMed ID: 15613334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and assessment of human adenovirus type 11 as a gene transfer vector.
    Stone D; Ni S; Li ZY; Gaggar A; DiPaolo N; Feng Q; Sandig V; Lieber A
    J Virol; 2005 Apr; 79(8):5090-104. PubMed ID: 15795294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene transduction and cell entry pathway of fiber-modified adenovirus type 5 vectors carrying novel endocytic peptide ligands selected on human tracheal glandular cells.
    Gaden F; Franqueville L; Magnusson MK; Hong SS; Merten MD; Lindholm L; Boulanger P
    J Virol; 2004 Jul; 78(13):7227-47. PubMed ID: 15194799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient gene transfer into human CD34+ cells by an adenovirus type 35 vector.
    Sakurai F; Mizuguchi H; Hayakawa T
    Gene Ther; 2003 Jun; 10(12):1041-8. PubMed ID: 12776162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dependence of adenovirus infectivity on length of the fiber shaft domain.
    Shayakhmetov DM; Lieber A
    J Virol; 2000 Nov; 74(22):10274-86. PubMed ID: 11044071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus 5 and chimeric adenovirus 5/F35 employ distinct B-lymphocyte intracellular trafficking routes that are independent of their cognate cell surface receptor.
    Drouin M; Cayer MP; Jung D
    Virology; 2010 Jun; 401(2):305-13. PubMed ID: 20347112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A capsid-modified adenovirus vector devoid of all viral genes: assessment of transduction and toxicity in human hematopoietic cells.
    Stecher H; Shayakhmetov DM; Stamatoyannopoulos G; Lieber A
    Mol Ther; 2001 Jul; 4(1):36-44. PubMed ID: 11472104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fiber-modified adenovirus vectors containing the TAT peptide derived from HIV-1 in the fiber knob have efficient gene transfer activity.
    Kurachi S; Tashiro K; Sakurai F; Sakurai H; Kawabata K; Yayama K; Okamoto H; Nakagawa S; Mizuguchi H
    Gene Ther; 2007 Aug; 14(15):1160-5. PubMed ID: 17508008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector.
    Shayakhmetov DM; Papayannopoulou T; Stamatoyannopoulos G; Lieber A
    J Virol; 2000 Mar; 74(6):2567-83. PubMed ID: 10684271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of replication-competent variants of adenovirus vectors and genome modifications to prevent their occurrence.
    Hehir KM; Armentano D; Cardoza LM; Choquette TL; Berthelette PB; White GA; Couture LA; Everton MB; Keegan J; Martin JM; Pratt DA; Smith MP; Smith AE; Wadsworth SC
    J Virol; 1996 Dec; 70(12):8459-67. PubMed ID: 8970968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein.
    Stevenson SC; Rollence M; Marshall-Neff J; McClelland A
    J Virol; 1997 Jun; 71(6):4782-90. PubMed ID: 9151872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of adenovirus serotype 35 vectors for efficient transduction in human hematopoietic progenitors: comparison of promoter activities.
    Sakurai F; Kawabata K; Yamaguchi T; Hayakawa T; Mizuguchi H
    Gene Ther; 2005 Oct; 12(19):1424-33. PubMed ID: 15944730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced transduction efficiency of fiber-substituted adenovirus vectors by the incorporation of RGD peptides in two distinct regions of the adenovirus serotype 35 fiber knob.
    Matsui H; Sakurai F; Katayama K; Kurachi S; Tashiro K; Sugio K; Kawabata K; Mizuguchi H
    Virus Res; 2011 Jan; 155(1):48-54. PubMed ID: 20801174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of fiber detargeting on adenovirus-mediated innate and adaptive immune activation.
    Schoggins JW; Nociari M; Philpott N; Falck-Pedersen E
    J Virol; 2005 Sep; 79(18):11627-37. PubMed ID: 16140740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fiber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors.
    Miyazawa N; Leopold PL; Hackett NR; Ferris B; Worgall S; Falck-Pedersen E; Crystal RG
    J Virol; 1999 Jul; 73(7):6056-65. PubMed ID: 10364358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus serotype 35 vector-induced innate immune responses in dendritic cells derived from wild-type and human CD46-transgenic mice: Comparison with a fiber-substituted Ad vector containing fiber proteins of Ad serotype 35.
    Sakurai F; Nakashima K; Yamaguchi T; Ichinose T; Kawabata K; Hayakawa T; Mizuguchi H
    J Control Release; 2010 Dec; 148(2):212-8. PubMed ID: 20800630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient delivery and stable gene expression in a hematopoietic cell line using a chimeric serotype 35 fiber pseudotyped helper-dependent adenoviral vector.
    Balamotis MA; Huang K; Mitani K
    Virology; 2004 Jun; 324(1):229-37. PubMed ID: 15183069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of high-capacity adenoviral vectors.
    Biermann V; Volpers C; Hussmann S; Stock A; Kewes H; Schiedner G; Herrmann A; Kochanek S
    Hum Gene Ther; 2001 Sep; 12(14):1757-69. PubMed ID: 11560769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.